Image-guided minimally invasive therapy

Urologic Oncology

Volumn , Issue , 2005, Pages 113-127

  Barnes, Agnieszka Szot ^a   Tempany, Clare M C ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33749325236     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7216-0003-1.50010-1     Document Type: Chapter

References (88)

1. Jolesz FA 1996 RSNA Eugene P. Pendergrass New Horizons Lecture 1997.
2. Silverman SG, Jolesz FA, Newman RW, et al. Design and implementation of an interventional MR imaging suite. Am J Roentgenol 1997, 168(6):1465-1471.
3. Chan DY, Solomon S, Kim FJ, Jarret TW Image-guided therapy in urology. J Endourol 2001, 15(February; 1):105-110.
4. Jolesz FA, Nabavi A, Kikinis R Integration of interventional MRI with computer-assisted surgery. J Magn Reson Imaging 2001, 13(1):69-77.
5. Comet-Batlle J, Vilanova-Busquets JC, Saladie-Roig JM, Gelabert-Mas A, Barcelo-Vidal C The value of endorectal MRI in the early diagnosis of prostate cancer. Eur Urol 2003, 44(August; 2):201-207. (Discussion 207-8).
6. Hricak H, White S, Vigneron D, Kurhanewicz J, Kosco A, Levin D, et al. Carcinoma of the prostate gland: MR imaging with pelvic phased-array coils versus integrated endorectal-pelvic phased-array coils. Radiology 1994, 193:703-709.
7. Barentsz JO, Engelbrecht M, Jager GJ, et al. Fast dynamic gadolinium-enhanced MR imaging of urinary bladder and prostate cancer. J Magn Reson Imaging 1999, 10(September; 3):295-304.
8. Huisman HJ, Engelbrecht MR, Barentsz JO Accurate estimation of pharmacokinetic contrast-enhanced dynamic MRI parameters of the prostate. J Magn Reson Imaging 2001, 3(April; 4):607-614.
9. Engelbrecht MR, Huisman HJ, Laheij RJ, et al. Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging. Radiology 2003, 229(October; 1):248-254. (Epub 2003 August 27).
10. Coakley FV, Qayyum A, Kurhanewicz J Magnetic resonance imaging and spectroscopic imaging of prostate cancer. J Urol 2003, 170(December; 6 Pt 2):S69-S75. (Discussion S75-6).
11. Kooy HM, Cormack RA, Mathiowitz G, Tempany C, D'Amico AV A software system for interventional magnetic resonance image-guided prostate brachytherapy. Comput Aided Surg 2000, 5(6):401-413.
12. Cline HE, Hynynen K, Hardy CJ, et al. MR temperature mapping of focused ultrasound surgery. Magn Reson Med 1994, 31(6):628-636.
13. Jolesz FA, Hynynen K Magnetic resonance image-guided focused ultrasound surgery. Cancer J 2002, 8(Suppl 1):S100-S112.
14. Hynynen K, Darkazanli A, Damianou CA, Unger E, Schenck JF Tissue thermometry during ultrasound exposure. Eur Urol 1993, 23(Suppl 1):12-16.
15. Fry WJ, Barnard JW, Fry FJ, Krunins RF, Brennan JF Ultrasonic lesions in mammalian central nervous system. Science 1955, 122:517.
16. Hynynen K, Pomeroy O, Smith DN, et al. MR imaging-guided focused ultrasound surgery of fibroadenomas in the breast: a feasibility study. Radiology 2001, 219(1):176-185.
17. Huber PE, Jenne JW, Rastert R, et al. A new noninvasive approach in breast cancer therapy using magnetic resonance imaging-guided focused ultrasound surgery. Cancer Res 2001, 61(23):8441-8447.
18. Tempany CM, Stewart EA, McDannold N, et al. MR imaging-guided focused ultrasound surgery of uterine leiomyomas: a feasibility study. Radiology 2003, 226(3):897-905.
19. Chinzei K, Hata N, Jolesz FA, Kikinis R Surgical assist robot for the active navigation in the intraoperative MRI: hardware design issues http://www.spl.harvard.edu:8000/pages/projects/robot-new/iros2000.pdf.
20. MR Compatible Surgical Robot System http://www.aist.go.jp/MEL/soshiki/kiso/biomech/chin/MMM/mrmani0-e.htm.
21. Pham DL, Xu C, Prince JL Current methods in medical image segmentation. Annu Rev Biomed Eng 2000, 2:315-337.
22. Soler L, Delingette H, Malandain G, et al. Fully automatic anatomical, pathological, and functional segmentation from CT scans for hepatic surgery. Comput Aided Surg 2001, 6(3):131-142.
23. EPIDAURE Research Project http://www-sop.inria.fr/epidaure/research.php.
24. Bogers HA, Sedelaar JP, Beerlage HP, et al. Contrast-enhanced three-dimensional power Doppler angiography of the human prostate: correlation with biopsy outcome. Urology 1999, 54(July; 1):97-104.
25. Wallner K, Roy J, Zelefsky M, Fuks Z, Harrison L Fluoroscopic visualization of the prostatic urethra to guide transperineal prostate implantation. Int J Radiat Oncol Biol Phys 1994, 29(4):863-867.
26. Lieberfarb ME, Schultz D, Whittington R, et al. Using PSA, biopsy Gleason score, clinical stage, and the percentage of positive biopsies to identify optimal candidates for prostate-only radiation therapy. Int J Radiat Oncol Biol Phys 2002, 53(4):898-903.
27. Jani AB, Hellman S Early prostate cancer: clinical decision-making. Lancet 2003, 361(9362):1045-1053.
28. Peschel RE, Colberg JW Surgery, brachytherapy, and external-beam radiotherapy for early prostate cancer. Lancet Oncol 2003, 4(4):233-241.
29. Ellis DS Cryosurgery as primary treatment for localized prostate cancer: a community hospital experience. Urology 2002, 60(2 Suppl 1):34-39.
30. Ghafar MA, Johnson CW, De La Taille A, et al. Salvage cryotherapy using an argon based system for locally recurrent prostate cancer after radiation therapy: the Columbia experience. J Urol 2001, 166(4):1333-1337. (Discussion 1337-8).
31. da la Taille A, Katz AE Cryosurgery: Is it an effective option for patients failing radiation?. Curr Opin Urol 2000, 10(5):409-413.
32. Gonder MJ, Soanes WA, Shulman S Cryosurgical treatment of the prostate. Invest Urol 1966, 3(4):372-378.
33. Onik GM, Cohen JK, Reyes GD Transrectal ultrasound-guided percutaneous radical cryosurgical ablation of the prostate. Cancer 1993, 72(4):1291-1299.
34. Donnelly BJ, Saliken JC, Ernst DS, et al. Prospective trial of cryosurgical ablation of the prostate: five-year results. Urology 2002, 60(4):645-649.
35. Long JP, Bahn D, Lee F, et al. Five-year retrospective, multi-institutional pooled analysis of cancer-related outcomes after cryosurgical ablation of the prostate. Urology 2001, 57(3):518-523.
36. Badalament RA, Bahn DK, Kim H, et al. Patient-reported complications after cryoablation therapy for prostate cancer. Arch Ital Urol Androl 2000, 72(4):305-312.
37. Robinson JW, Moritz S, Fung T Meta-analysis of rates of erectile function after treatment of localized prostate carcinoma. Int J Radiat Oncol Biol Phys 2002, 54(4):1063-1068.
38. Onik G, Narayan P, Vaughan D, Dineen M, Brunelle R Focal "nerve-sparing" cryosurgery for treatment of primary prostate cancer: a new approach to preserving potency. Urology 2002, 60(1):109-114.
39. Bice WS, Freeman JE, Russell LF, et al. Use of image coregistration in salvage prostate brachytherapy. Tech Urol 2000, 6(2):151-156.
40. Beyer DC Permanent brachytherapy as salvage treatment for recurrent prostate cancer. Urology 1999, 54(5):880-883.
41. D'Amico AV Analysis of the clinical utility of the use of salvage brachytherapy in patients who have a rising PSA after definitive external beam radiation therapy. Urology 1999, 54(2):201-203.
42. Scardino PT, Carlton CE Combined interstitial and external irradiation for prostatic cancer. Principles and Management of Urologic Cancer 1983, 392-408. Williams and Williams, Baltimore. N. Javadpour (Ed.).
43. Holm HH, Juul N, Pedersen JF, Hansen H, Stroyer I Transperineal 125 iodine seed implantation in prostatic cancer guided by transrectal ultrasonography. J Urol 1983, 130(2):283-286.
44. D'Amico AV, Cormack R, Tempany CM, et al. Real-time magnetic resonance image-guided interstitial brachytherapy in the treatment of select patients with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 1998, 42(3):507-515.
45. Kaplan ID, Holupka EJ, Meskell P, et al. Intraoperative treatment planning for radioactive seed implant therapy for prostate cancer. Urology 2000, 56(3):492-495.
46. Grimm PD, Blasko JC, Sylvester JE, Meier RM, Cavanagh W Ten-year biochemical (prostate-specific antigen) control of prostate cancer with (125)I brachytherapy. Int J Radiat Oncol Biol Phys 2001, 51(1):31-40.
47. Ragde H, Elgamal AA, Snow PB, et al. Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-gray external beam irradiation in the treatment of patients with clinically localized, low to high Gleason grade prostate carcinoma. Cancer 1998, 83(5):989-1001.
48. Blasko JC, Grimm PD, Sylsvester JE, Cavanagh W The role of external beam radiotherapy with I-125/Pd-103 brachytherapy for prostate carcinoma. Radiother Oncol 2000, 57(3):273-278.
49. Blasko JC, Grimm PD, Sylvester JE, et al. Palladium-103 brachytherapy for prostate carcinoma. Int J Radiat Oncol Biol Phys 2000, 46(4):839-850.
50. Potters L, Cha C, Oshinsky G, et al. Risk profiles to predict PSA relapse-free survival for patients undergoing permanent prostate brachytherapy. Cancer J Sci Am 1999, 5(5):301-306.
51. Beyer DC, Brachman DG Failure free survival following brachytherapy alone for prostate cancer: comparison with external beam radiotherapy. Radiother Oncol 2000, 57(3):263-267.
52. Merrick GS, Butler WM, Tollenaar BG, Galbreath RW, Lief JH The dosimetry of prostate brachytherapy-induced urethral strictures. Int J Radiat Oncol Biol Phys 2002, 52(2):461-468.
53. Merrick GS, Butler WM, Galbreath RW, et al. Erectile function after permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 2002, 52(4):893-902.
54. Stock RG, Kao J, Stone NN Penile erectile function after permanent radioactive seed implantation for treatment of prostate cancer. J Urol 2001, 165(2):436-439.
55. Talcott JA, Clark JA, Stark PC, Mitchell SP Long-term treatment related complications of brachytherapy for early prostate cancer: a survey of patients previously treated. J Urol 2001, 166(2):494-499.
56. Koutrouvelis P, Lailas N, Katz S, et al. High- and low-risk prostate cancer treated with 3D CT-guided brachytherapy: 1- to 5-year follow-up. J Endourol 2000, 14(4):357-366.
57. Koutrouvelis PG Three-dimensional stereotactic posterior ischiorectal space computerized tomography guided brachytherapy of prostate cancer: a preliminary report. J Urol 1998, 159(1):142-145.
58. Molloy JA, Williams MB Treatment planning considerations and quality assurance for CT-guided transischiorectal implantation of the prostate. Med Phys 1999, 26(9):1943-1951.
59. Koutrouvelis PG, Lailas N, Katz S, et al. Prostate cancer with large glands treated with three-dimensional computerized tomography guided pararectal brachytherapy: up to 8 years of followup. J Urol 2003, 169(4):1331-1336.
60. D'Amico AV, Tempany CM, Schultz D, et al. Comparing PSA outcome after radical prostatectomy or magnetic resonance imaging-guided partial prostatic irradiation in select patients with clinically localized adenocarcinoma of the prostate. Urology 2003, 62(6):1063-1067.
61. D'Amico A, Cormack R, Kumar S, Tempany CM Real-time magnetic resonance imaging-guided brachytherapy in the treatment of selected patients with clinically localized prostate cancer. J Endourol 2000, 14(4):367-370.
62. Thomas MD, Cormack R, Tempany CM, et al. Identifying the predictors of acute urinary retention following magnetic-resonance-guided prostate brachytherapy. Int J Radiat Oncol Biol Phys 2000, 47(4):905-908.
63. Albert M, Tempany CM, Schultz D, et al. Late genitourinary and gastrointestinal toxicity after magnetic resonance image-guided prostate brachytherapy with or without neoadjuvant external beam radiation therapy. Cancer 2003, 98(5):949-954.
64. Clark JA, Talcott JA Symptom indexes to assess outcomes of treatment for early prostate cancer. Med Care 2001, 39(10):1118-1130.
65. Gelet A, Chapelon JY, Margonari J, et al. Prostatic tissue destruction by high-intensity focused ultrasound: experimentation on canine prostate. J Endourol 1993, 7(3):249-253.
66. Gelet A, Chapelon JY, Bouvier R, et al. Treatment of prostate cancer with transrectal focused ultrasound: early clinical experience. Eur Urol 1996, 29(2):174-183.
67. Gelet A, Chapelon JY, Bouvier R, et al. Transrectal high intensity focused ultrasound for the treatment of localized prostate cancer: factors influencing the outcome. Eur Urol 2001, 40(2):124-129.
68. Gelet A, Chapelon JY, Bouvier R, et al. Transrectal high-intensity focused ultrasound: minimally invasive therapy of localized prostate cancer. J Endourol 2000, 14(6):519-528.
69. Chaussy CG, Thuroff S High-intensive focused ultrasound in localized prostate cancer. J Endourol 2000, 14(3):293-299.
70. Gelet A, Chapelon JY, Bouvier R, Pangaud C, Lasne Y Local control of prostate cancer by transrectal high intensity focused ultrasound therapy: preliminary results. J Urol 1999, 161(1):156-162.
71. Beerlage HP, Thuroff S, Debruyne FM, Chaussy C, de la Rosette JJ Transrectal high-intensity focused ultrasound using the Ablatherm device in the treatment of localized prostate carcinoma. Urology 1999, 54(2):273-277.
72. Uchida T, Sanghvi NT, Gardner TA, et al. Transrectal high-intensity focused ultrasound for treatment of patients with stage T1b-2n0m0 localized prostate cancer: a preliminary report. Urology 2002, 59(3):394-398. (Discussion 398-9).
73. Blana A, Walter B, Rogenhofer S, Wieland WF High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience. Urology 2004, 63(2):297-300.
74. Lee F, Gray JM, McLeary RD, et al. Prostatic evaluation by transrectal sonography: criteria for diagnosis of early carcinoma. Radiology 1986, 158(1):91-95.
75. Lee F, Gray JM, McLeary RD, et al. Transrectal ultrasound in the diagnosis of prostate cancer: location, echogenicity, histopathology, and staging. Prostate 1985, 7(2):117-129.
76. Rifkin MD, Kurtz AB, Goldberg BB Prostate biopsy utilizing transrectal ultrasound guidance: diagnosis of nonpalpable cancers. J Ultrasound Med 1983, 2(4):165-167.
77. Keetch DW, McMurtry JM, Smith DS, Andriole GL, Catalona WJ Prostate specific antigen density versus prostate specific antigen slope as predictors of prostate cancer in men with initially negative prostatic biopsies. J Urol 1996, 156(2 Pt 1):428-431.
78. Terris MK Sensitivity and specificity of sextant biopsies in the detection of prostate cancer: preliminary report. Urology 1999, 54(3):486-489.
79. Terris MK, McNeal JE, Freiha FS, Stamey TA Efficacy of transrectal ultrasound-guided seminal vesicle biopsies in the detection of seminal vesicle invasion by prostate cancer. J Urol 1993, 149(5):1035-1039.
80. Applewhite JC, Matlaga BR, McCullough DL, Hall MC Transrectal ultrasound and biopsy in the early diagnosis of prostate cancer. Cancer Control 2001, 8(March-April; 2):141-150.
81. Eskew LA, Bare RL, McCullough DL Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate. J Urol 1997, 157(January; 1):199-202. (Discussion 202-3).
82. Chang JJ, Shinohara K, Bhargava V, Presti JC Prospective evaluation of lateral biopsies of the peripheral zone for prostate cancer detection. J Urol 1998, 60(December; 6 Pt 1):2111-2114.
83. Chen ME, Troncoso P, Johnston DA, Tang K, Babaian RJ Optimization of prostate biopsy strategy using computer based analysis. J Urol 1997, 58(December; 6):2168-2175.
84. Babaian RJ, Toi A, Kamoi K, et al. A comparative analysis of sextant and an extended 11-core multisite directed biopsy strategy. J Urol 2000, 163(January; 1):152-157.
85. Naughton CK, Miller DC, Mager DE, Ornstein DK, Catalona WJ A prospective randomized trial comparing 6 versus 12 prostate biopsy cores: impact on cancer detection. J Urol 2000, 164(August; 2):388-392.
86. Hata N, Jinzaki M, Kacher D, et al. MR imaging-guided prostate biopsy with surgical navigation software: device validation and feasibility. Radiology 2001, 220(1):263-268.
87. Cormack RA, D'Amico AV, Hata N, et al. Feasibility of transperineal prostate biopsy under interventional MR guidance. Urology 2000, 56(4):663-664.
88. D'Amico AV, Tempany CM, Cormack R, et al. Transperineal magnetic resonance image guided prostate biopsy. J Urol 2000, 164(2):385-387.